A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen monitoring technology.
It’s an impressive accomplishment for the new mega-rocket launch system, and paves the way for the company to start re-using the boosters in commercial missions.
The platform has attracted an eclectic user base. More than half of Fortune 500 companies are using Lovable to “supercharge creativity,” according to Osika, who insisted retention remains strong.